{"id":563,"date":"2020-04-23T15:29:11","date_gmt":"2020-04-23T13:29:11","guid":{"rendered":"https:\/\/aagato.com\/actualites\/"},"modified":"2020-04-23T15:30:26","modified_gmt":"2020-04-23T13:30:26","slug":"actualites","status":"publish","type":"page","link":"https:\/\/aagato.com\/fr\/actualites\/","title":{"rendered":"Actualit\u00e9s"},"content":{"rendered":"[vc_row][vc_column]<div class=\"vcex-module vcex-blog-grid-wrap vcex-clr\"><div class=\"wpex-row vcex-blog-grid wpex-clr entries\"><div class=\"vcex-blog-entry vcex-grid-item entry-has-details span_1_of_1 col-1 col post-907 entry type-post no-media cat-13 translation_priority-15\"><div class=\"vcex-blog-entry-inner entry-inner wpex-clr\"><div class=\"vcex-blog-entry-details entry-details wpex-clr\"><h2 class=\"vcex-blog-entry-title entry-title\"><a href=\"https:\/\/aagato.com\/fr\/equashields-cstds-strategic-healthcare-investment\/\">Equashield\u2019s CSTDs Strategic Healthcare Investment<\/a><\/h2><div class=\"vcex-blog-entry-date entry-date\">5 mars 2024<\/div><div class=\"vcex-blog-entry-excerpt entry-excerpt entry clr\"><\/div><div class=\"vcex-blog-entry-readmore-wrap entry-readmore-wrap clr\"><a href=\"https:\/\/aagato.com\/fr\/equashields-cstds-strategic-healthcare-investment\/\" class=\"theme-button\">read more<\/a><\/div><\/div><\/div><\/div><div class=\"vcex-blog-entry vcex-grid-item entry-has-details span_1_of_1 col-1 col post-906 entry type-post no-media cat-13 translation_priority-15\"><div class=\"vcex-blog-entry-inner entry-inner wpex-clr\"><div class=\"vcex-blog-entry-details entry-details wpex-clr\"><h2 class=\"vcex-blog-entry-title entry-title\"><a href=\"https:\/\/aagato.com\/fr\/an-assessment-of-exposed-syringe-inner-walls-as-a-route-of-exposure-from-hazardous-drugs\/\">An assessment of exposed syringe inner walls as a route of exposure from hazardous drugs<\/a><\/h2><div class=\"vcex-blog-entry-date entry-date\">5 mars 2024<\/div><div class=\"vcex-blog-entry-excerpt entry-excerpt entry clr\"><\/div><div class=\"vcex-blog-entry-readmore-wrap entry-readmore-wrap clr\"><a href=\"https:\/\/aagato.com\/fr\/an-assessment-of-exposed-syringe-inner-walls-as-a-route-of-exposure-from-hazardous-drugs\/\" class=\"theme-button\">read more<\/a><\/div><\/div><\/div><\/div><div class=\"vcex-blog-entry vcex-grid-item entry-has-details span_1_of_1 col-1 col post-893 entry type-post no-media cat-13 translation_priority-15\"><div class=\"vcex-blog-entry-inner entry-inner wpex-clr\"><div class=\"vcex-blog-entry-details entry-details wpex-clr\"><h2 class=\"vcex-blog-entry-title entry-title\"><a href=\"https:\/\/aagato.com\/fr\/avis-dexpert-contamination-de-la-paroi-interne-dune-seringue-standard\/\">Avis d&#8217;expert: Contamination de la paroi interne d&#8217;une seringue standard<\/a><\/h2><div class=\"vcex-blog-entry-date entry-date\">19 avril 2022<\/div><div class=\"vcex-blog-entry-excerpt entry-excerpt entry clr\"><p>Avis d'expert par Johan Vandenbroucke Pharmacien Hospitalier En 2005 et 2014, une \u00e9tude a \u00e9t\u00e9&hellip;<\/p><\/div><div class=\"vcex-blog-entry-readmore-wrap entry-readmore-wrap clr\"><a href=\"https:\/\/aagato.com\/fr\/avis-dexpert-contamination-de-la-paroi-interne-dune-seringue-standard\/\" class=\"theme-button\">read more<\/a><\/div><\/div><\/div><\/div><div class=\"vcex-blog-entry vcex-grid-item entry-has-details span_1_of_1 col-1 col post-881 entry type-post no-media cat-13 translation_priority-15\"><div class=\"vcex-blog-entry-inner entry-inner wpex-clr\"><div class=\"vcex-blog-entry-details entry-details wpex-clr\"><h2 class=\"vcex-blog-entry-title entry-title\"><a href=\"https:\/\/aagato.com\/fr\/newly-published-peer-reviewed-study-shows-ef%ef%ac%81cacy-of-equashield-cstd-in-preventing-hazardous-drug-contamination-when-compounding-cytotoxic-medications-in-realworld-setting\/\">Newly Published Peer-Reviewed Study Shows Ef\ufb01cacy of Equashield CSTD in Preventing Hazardous Drug Contamination When Compounding Cytotoxic Medications in RealWorld Setting<\/a><\/h2><div class=\"vcex-blog-entry-date entry-date\">25 ao\u00fbt 2021<\/div><div class=\"vcex-blog-entry-excerpt entry-excerpt entry clr\"><p>PORT WASHINGTON, New York, Aug. 24, 2021 \/PRNewswire\/ -- Equashield (equashield.com), a leading provider of&hellip;<\/p><\/div><div class=\"vcex-blog-entry-readmore-wrap entry-readmore-wrap clr\"><a href=\"https:\/\/aagato.com\/fr\/newly-published-peer-reviewed-study-shows-ef%ef%ac%81cacy-of-equashield-cstd-in-preventing-hazardous-drug-contamination-when-compounding-cytotoxic-medications-in-realworld-setting\/\" class=\"theme-button\">read more<\/a><\/div><\/div><\/div><\/div><\/div><\/div>[\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/aagato.com\/fr\/wp-json\/wp\/v2\/pages\/563"}],"collection":[{"href":"https:\/\/aagato.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aagato.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aagato.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aagato.com\/fr\/wp-json\/wp\/v2\/comments?post=563"}],"version-history":[{"count":1,"href":"https:\/\/aagato.com\/fr\/wp-json\/wp\/v2\/pages\/563\/revisions"}],"predecessor-version":[{"id":564,"href":"https:\/\/aagato.com\/fr\/wp-json\/wp\/v2\/pages\/563\/revisions\/564"}],"wp:attachment":[{"href":"https:\/\/aagato.com\/fr\/wp-json\/wp\/v2\/media?parent=563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}